Dudu Khumalo News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Dudu khumalo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Dudu Khumalo Today - Breaking & Trending Today
Philanthrocapitalism seen from South Africa cadtm.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cadtm.org Daily Mail and Mail on Sunday newspapers.
Philanthrocapitalism seen from South Africa cadtm.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cadtm.org Daily Mail and Mail on Sunday newspapers.
Holiday travelers at Hartsfield-Jackson International Airport in Atlanta on Dec. 23.Credit.Nicole Craine for The New York Times Sunday was the busiest day for U.S. airports since mid-March, underscoring concerns that a spike in holiday travel may contribute to the spread of the coronavirus, even as new cases remain alarmingly high and officials plead with Americans to avoid taking unnecessary risks. The Transportation Security Administration screened nearly 1.3 million people on Sunday, the most since March 15, when airline passenger numbers were in free-fall as the pandemic began to take hold within the United States. Since then, the number of travelers screened at airports has exceeded one million fewer than a dozen times, including around Thanksgiving and Christmas. ....
Beginning Sunday, shipments totaling 5.9 million doses of the Moderna vaccine may be sent to rural areas, smaller hospitals and local health departments. The first shots are expected to be given Monday.Credit.Andrew Kelly/Reuters The Food and Drug Administration on Friday authorized the Covid-19 vaccine made by Moderna for emergency use, allowing the shipment of millions more doses across the nation and intensifying the debate over who will be next in line to get inoculated. The move will make Moderna’s vaccine the second to reach the American public, after the one by Pfizer and BioNTech, which was authorized just one week ago. ....